Laboratory testing in disseminated intravascular coagulation

Seminars in Thrombosis and Hemostasis

Volumn 27, Issue 6, 2001, Pages 653-656

  Cheng Hock Toh, ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

DIC; Disseminated intravascular coagulation; Laboratory tests; Prothrombin time; Scoring system; Standardization

Indexed keywords

ACTIVATED PROTEIN C; ANTIPLASMIN; BIOLOGICAL MARKER; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; FIBRINOPEPTIDE A; PLASMIN; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; BIOASSAY; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; LABORATORY TEST; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SCORING SYSTEM; STANDARDIZATION; THROMBIN TIME; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

ANIMALS; BIOLOGICAL MARKERS; DISSEMINATED INTRAVASCULAR COAGULATION; HEMATOLOGIC TESTS; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0035216945     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18869     Document Type: Article

References (23)

1. Disseminated intravascular coagulation: Findings in 346 patients
2. Septic shock
3. Clinical and laboratory aspects of disseminated intravascular coagulation: A study of 118 cases
4. Disseminated intravascular coagulation
5. The incidence and significance of hemostatic abnormalities in patients with head injuries
6. Disseminated intravascular coagulation: Pathophysiological mechanisms and manifestations
7. Disseminated intravascular coagulation: An approach
8. D-Dimer plasma concentration in various clinical conditions
9. Criteria for diagnosis of DIC based on analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan
10. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun
11. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients
12. Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality
13. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome
14. Hemostatic study before onset of disseminated intravascular coagulation
15. The use of soluble fibrin in evaluating the acute and chronic hypercoaguable state
16. Comparison of thromboelastography with common coagulation tests
17. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification
18. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation
19. Thromboplastin sensitivity in waveform analysis
20. Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis
21. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxaemia
22. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli
23. Treating patients with severe sepsis